What Medicare could do to get you lower drug prices
Medicare has zillions of rules. But there's one more that columnist Philip Moeller would like to see adopted. Right now, Medicare beneficiaries are pawns in the drug pricing system, and plenty of Americans don't take the drugs they need because…
Watch
Pfizer-AstraZeneca deal could impact drug development
Pfizer made a $106 billion bid for the British drug maker AstraZeneca this week in a move that was potentially motivated by lower corporate tax rates overseas. The deal could also affect the development of new drugs. Hari Sreenivasan speaks…
Watch
Vaccine Producers Victorious in Supreme Court Ruling Over Lawsuits
Judy Woodruff talks with the National Law Journal's Marcia Coyle about the Supreme Court's 6-2 ruling making it more difficult for parents who say their children were injured by vaccines to file lawsuits against drug makers.
Democrats Revolt Over $80 Billion Pharmaceutical Deal
Senate Finance Committee Chairman Max Baucus faced the first major fight over his health care legislation Tuesday, as fellow Democrats challenged the $80 billion deal that he and the White House struck with drug makers to help pay for health…
